Growth factors in steroid-responsive prostatic tumor cells

Steroids

Volumn 61, Issue 4, 1996, Pages 222-225

  Dondi, Donatella ^a   Moretti, Roberta M ^a   Marelli, Marina Montagnani ^a   Motta, Marcella ^a   Limonta, Patrizia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Center for Endocrinological Oncology   (Italy)

Author keywords

epidermal growth factor; luteinizing hormone releasing hormone (LHRH); prostate; receptor; testosterone; tumor

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR; GONADORELIN; GOSERELIN; TESTOSTERONE;

CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH STIMULATION; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; MITOGENESIS; ONCOGENE C FOS; PROSTATE TUMOR; PROTO ONCOGENE; REGULATORY MECHANISM; TUMOR CELL LINE;

EID: 0029880491     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(96)00018-9     Document Type: Conference Paper

References (31)

1. Hodges CV (1979). Hormone therapy in prostatic cancer. In: Rose DP (ed), Endocrinology of Cancer, Vol. II, CRC Press, Inc., Boca Raton, FL, pp. 57-67.
2. Gittes RF (1991). Carcinoma of the prostate. N Engl J Med 324: 236-245.
3. Wilding G (1992). The importance of steroid hormones in prostate cancer. Cancer Surv 14:113-130.
4. Crawford ED, DeAntonio EP, Labrie F, Schroder FH, Geller J (1995). Endocrine therapy of prostate cancer: optimal form and appropriate timing. J Clin Endocr Metab 80:1062-1078.
5. Connolly JM, Rose DP (1990). Production of epidermal growth factor and transforming growth factor-α by the androgen-responsive LNCaP human cancer cell line. Prostate 16:209-218.
6. MacGrogan D, Saint-Andre JP, Dicou E (1992). Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J Neurochem 59:1381-1391.
7. Knabbe C, Klein H, Zugmaier G, Voigt K-D (1993). Hormonal regulation of transforming growth factor β-2 expression in human prostate cancer. J Steroid Biochem Mol Biol 47:137-142.
8. Liu X-H, Wiley HS, Meikle AW (1993). Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)/TGF-α receptor. J Clin Endocr Metab 77:1472-1478.
9. Sehgal I, Powers S, Huntley B, Powis G, Pittelkow M, Mahile NJ (1994). Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc Natl Acad Sci USA 91:4673-4677.
10. Helle SI, Lonning PE (1995). Insulin-like growth factors in breast and prostatic cancer. Endocr-Rel Cancer 2:153-169.
11. Schuurmans ALG, Bolt J, Veldscholte J, Mulder E (1991). Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40:193-197.
12. Ravenna L, Lubrano C, Di Silverio F, Vacca A, Felli MP, Maroder M, D'Eramo G, Sciarra F, Frati L, Gulino A, Petrangeli E (1995). Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP. Prostate 26:290-298.
13. Limonta P, Dondi D, Moretti RM, Fermo D, Garattini E, Motta M (1993). Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP. J Clin Endocr Metab 76:797-800.
14. Limonta P, Dondi D, Moretti RM, Maggi R, Motta M (1992). Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP. J Clin Endocr Metab 75:207-212.
15. Qayum A, Gullick W, Clayton RC, Sikora K, Waxman J (1990). The effects of gonadotrophin releasing hormone analogues in prostatic cancer cell lines. Br J Cancer 62:96-99.
16. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983). LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818.
17. Henttu P, Liao S, Vihko P (1992). Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130:766-772.
18. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GGJM, Jenster G, Trapman J, Brinkmann AO, Mulder E (1992). The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41:665-669.
19. Trapman J, Klaassen P, Kuiper GGJM, van der Korput JAGM, Faber PW, van Rooij HCJ, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO (1988). Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 153:241-248.
20. Brinkmann AO, Faber PW, van Rooij HCJ, Kuiper GGJM, Ris C, Klaassen P, van der Korput JAGM, Voorhorst MM, van Laar JH, Mulder E, Trapman J (1989). The human androgen receptor: domain, structure, genomic organization and regulation of expression. J Steroid Biochem 34:307-310.
21. Krongrad A, Wilson MC, Wilson JD, Allman DR, McPhaul MJ (1991). Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 76: 79-88.
22. Chirgwin J, Aeyble A, McDonald R, Rutter W (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
23. Chang C, Kokontis J, Liao S (1988). Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 85:7211-7215.
24. Mizokami A, Saiga H, Matsui T, Mita T, Sugita A (1992). Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP. Endocrinol Jpn 39:235-243.
25. MacDonald A, Habib FK (1992). Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 65:177-182.
26. Limonta P, Moretti RM, Dondi D, Montagnani Marelli M, Motta M (1994). The EGF/TGFα system as an autocrine growth stimulatory loop in LNCaP cells. Endocr-Rel Cancer 3:5-13.
27. Fekete M, Redding TW, Comaru-Schally AM, Pontes JE, Connelly RW, Srkalovic G, Schally AV (1989). Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia. Prostate 14:191-208.
28. Carpenter G, Cohen S (1990). Epidermal growth factor. J Biol Chem 265:7709-7712.
29. Ullrich A, Schlessinger J (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
30. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
31. Lee MT, Liebow C, Kamer AR, Schally AV (1991). Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 88:1656-1660.